Documents | Asfotase alfa for treating paediatric-onset hypophosphatasia | Guidance | NICE

Documents

A list of downloadable documents created during development.

Expected publication

Equality Impact Assessment (Guidance development) ^{PDF 232.98 KB} 02 August 2017

Final evaluation determination

Final evaluation determination
Final evaluation determination document ^{PDF 590.16 KB} 05 July 2017
Committee papers ^{PDF 394.98 KB} 05 July 2017
Public committee slides ^{PDF 254.82 KB} 05 July 2017

Appeal

Appeal
Alexion : Appeal letter ^{PDF 1.33 MB} 20 April 2017
NICE : Scrutiny letter ^{MSWord 59.08 KB} 20 April 2017
Alexion : Response to scrutiny letter ^{PDF 377.05 KB} 20 April 2017
Alexion : Response to scrutiny letter ^{PDF 374.17 KB} 20 April 2017
Alexion : Response to scrutiny letter ^{PDF 125.15 KB} 20 April 2017
NICE : Final scrutiny letter ^{MSWord 57 KB} 20 April 2017
Alexion : Written submission ^{PDF 297.5 KB} 20 April 2017
British Pediatric and Adolescent Bone Group : Appeal letter ^{PDF 75.43 KB} 20 April 2017
British Pediatric and Adolescent Bone Group : Scrutiny letter ^{MSWord 55.65 KB} 20 April 2017
British Pediatric and Adolescent Bone Group : Final scrutiny letter ^{MSWord 54.71 KB} 20 April 2017
Children Living with Inherited Metabolic Diseases : Appeal letter ^{PDF 166.46 KB} 20 April 2017
NICE : Scrutiny letter ^{MSWord 57.06 KB} 20 April 2017
Children Living with Inherited Metabolic Diseases : Response to scrutiny letter ^{MSWord 31.04 KB} 20 April 2017
NICE : Final scrutiny letter ^{MSWord 55.45 KB} 20 April 2017
Royal College of Pathologists : Appeal letter ^{MSWord 61 KB} 20 April 2017
NICE : Scrutiny letter ^{MSWord 55.81 KB} 20 April 2017
NICE : Final scrutiny letter ^{MSWord 54.39 KB} 20 April 2017

Final evaluation determination

Final evaluation determination
Final evaluation determination document ^{PDF 797.37 KB} 07 February 2017
Committee papers ^{PDF 1.23 MB} 07 February 2017

Evaluation consultation

Evaluation consultation
Evaluation consultation document ^{PDF 548.47 KB} 22 September 2016
Committee papers ^{PDF 1.22 MB} 22 September 2016

Evaluation consultation

Evaluation consultation
Evaluation consultation document ^{PDF 518.28 KB} 03 December 2015
Committee papers ^{PDF 11.64 MB} 27 September 2016

Hypophosphatasia - asfotase alfa (paediatric-onset) [ID758]: final scope

Hypophosphatasia - asfotase alfa (paediatric-onset) [ID758]: final scope ^{PDF 100.5 KB} 04 December 2014

Hypophosphatasia - asfotase alfa (paediatric-onset) [ID758]: final matrix

Hypophosphatasia - asfotase alfa (paediatric-onset) [ID758]: final matrix ^{PDF 98.68 KB} 04 December 2014

Hypophosphatasia - asfotase alfa (paediatric-onset) [ID758]: NICE response to consultee and commentator comments on the draft scope and provisional matrix

Hypophosphatasia - asfotase alfa (paediatric-onset) [ID758]: NICE response to consultee and commentator comments on the draft scope and provisional matrix ^{PDF 282.75 KB} 05 December 2014

Hypophosphatasia - asfotase alfa (paediatric-onset) [ID758]: equality impact assessment - scoping

Hypophosphatasia - asfotase alfa (paediatric-onset) [ID758]: equality impact assessment - scoping ^{PDF 62.95 KB} 04 December 2014

Hypophosphatasia - asfotase alfa (paediatric-onset) [ID758]: draft scope (pre-referral) - June 2014

Hypophosphatasia - asfotase alfa (paediatric-onset) [ID758]: draft scope ^{PDF 110.5 KB} 26 November 2014

Hypophosphatasia - asfotase alfa (paediatric-onset) [ID758]: provisional matrix (pre-referral) - June 2014

Hypophosphatasia - asfotase alfa (paediatric-onset) [ID758]: provisional matrix ^{PDF 98 KB} 26 November 2014